Midleton, Ireland

Colin Langan

This inventor holds 2 USPTO granted patents and 3 EPO patents. Top assignee: Stryker European Operations Limited. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Colin Langan. Retrieved from https://idiyas.com/inventor/colin-langan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.2

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Colin Langan - Innovator at Stryker European Operations Limited

Introduction

Colin Langan is an accomplished inventor based in Midleton, Co. Cork, Ireland. He is currently associated with Stryker European Operations Limited, a leading company in the medical technology sector. Although he holds no patents at this time, his contributions to the field are noteworthy.

Latest Patents

Colin Langan currently has 2 patents. This indicates that he may be in the early stages of his innovative journey or focusing on collaborative projects within his company.

Career Highlights

Throughout his career, Colin has been involved in various projects that aim to enhance medical technologies. His work at Stryker European Operations Limited has allowed him to contribute to advancements in healthcare solutions.

Collaborations

Due to space constraints, the details of Colin's collaborations will not be included in this article.

Conclusion

Colin Langan is a promising inventor whose work at Stryker European Operations Limited highlights his commitment to innovation in the medical field. His future endeavors may lead to significant contributions to healthcare technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…